Lifetime Cost Effectiveness of Phenylketonuria Screening Na-tional Program in Iran
Background: Phenylketonuria (PKU) is an autosomal recessive disorder that screening and timely control of this disorder can prevent the adverse effects. Regarding the high prevalence of PKU in Iran, the PKU screening program was started in Iran in 2006. This study was conducted to determine the cos...
Guardado en:
Autores principales: | Alireza Heidari, Mohammad Arab, Behzad Damari |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Tehran University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d329c8e167cc4ad4ba25f7b96aa5bc6a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An Updated <i>PAH</i> Mutational Spectrum of Phenylketonuria in Mexican Patients Attending a Single Center: Biochemical, Clinical-Genotyping Correlations
por: Marcela Vela-Amieva, et al.
Publicado: (2021) -
Evaluation of Nutritional Status and Growth in Phenylketonuria Patients in Mazandaran Province Iran
por: Eshraghi P, Abbaskhanian A, Bijani A, Hosseinzadeh S
Publicado: (2011) -
Improving phenylalanine and micronutrients status of children with phenylketonuria: a pilot randomized study
por: Reza Zamani, et al.
Publicado: (2021) -
Telehealth and COVID-19: Empowering Standards of Management for Patients Affected by Phenylketonuria and Hyperphenylalaninemia
por: Valentina Rovelli, et al.
Publicado: (2021) -
Italian national consensus statement on management and pharmacological treatment of phenylketonuria
por: Alberto Burlina, et al.
Publicado: (2021)